@article{ce8e73768d274fe8972ee4f75810eee4,
title = "Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact",
author = "Daniel Gonzalez and Rao, {Gauri G.} and Bailey, {Stacy C.} and Brouwer, {Kim L.R.} and Yanguang Cao and Crona, {Daniel J.} and Kashuba, {Angela D.M.} and Lee, {Craig R.} and Kathryn Morbitzer and Patterson, {J. Herbert} and Tim Wiltshire and Jon Easter and Savage, {Scott W.} and Powell, {J. Robert}",
note = "Funding Information: research from the National Institute of Child Health and Human Development (K23HD083465), the nonprofit organization Thrasher Research Fund (www.thrasherresearch.org), and from industry (Cempra, Inc. and Jacobus Pharmaceutical Company, Inc.) for drug development in adults and children. S.C.B. has served as a consultant to Merck, Sharp and Dohme and to Luto (UK). She has received funding via her institution from Merck, Sharp and Dohme, Eli Lilly Company, AHRQ, and the National Institutes of Health for studies that use the electronic health record to improve prescribing and patient monitoring. Y.C. recieves support from the National Institute of General Medical Sciences (GM119661). K.L.R.B. receives support from the National Institute of General Medical Sciences through award numbers R01GM041935 and R35GM122576, and from industry (Otsuka Pharmaceutical Development and Commercialization, Inc., and Intercept Pharmaceuticals). K.L.R.B. is a coinventor of the sandwich-cultured hepatocyte technology for quantification of biliary excretion (B-CLEAR) and related technologies, which have been licensed exclusively to Qualyst Transporter Solutions, LLC. A.D.M.K. receives support for research from the National Institute of Allergy and Infectious Diseases (R01AI122319, R01AI111891, P30AI050410, R01AI116276, R01AI117739, U01AI103390, UM1AI126619), the National Center for Advancing Translational Sciences (UL1TR001111), the National Institute of Child Health and Human Development (K12HD001441), and from industry (Gilead, Merck) for clinical pharmacology and drug development. C.R.L. receives research support from the American Heart Association (16GRNT29300003). J.R.P. has served as paid consultant to Takeda, AbbVie, and Hengrui Pharmaceuticals over the past year. The remaining authors have no conflicts to disclose. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.",
year = "2017",
month = nov,
doi = "10.1111/cts.12490",
language = "English (US)",
volume = "10",
pages = "443--454",
journal = "Clinical and Translational Science",
issn = "1752-8054",
publisher = "Wiley-Blackwell",
number = "6",
}
